Christopher L D McMillan
Christopher L D McMillan
1School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072 Australia
1,✉,
Stacey T M Cheung
Stacey T M Cheung
1School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072 Australia
1,
Naphak Modhiran
Naphak Modhiran
1School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072 Australia
1,
James Barnes
James Barnes
2WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000 Australia
2,
Alberto A Amarilla
Alberto A Amarilla
1School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072 Australia
1,
Helle Bielefeldt-Ohmann
Helle Bielefeldt-Ohmann
1School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072 Australia
3Australian Infectious Diseases Research Centre, Global Virus Network Centre of Excellence, Brisbane, QLD 4072 and 4029 Australia
4School of Veterinary Science, The University of Queensland Gatton Campus, Gatton, QLD 4343 Australia
1,3,4,
Leo Yi Yang Lee
Leo Yi Yang Lee
2WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000 Australia
2,
Kate Guilfoyle
Kate Guilfoyle
5Viroclinics Xplore, Landerd Campus, Nistelrooise Baan 3, 5374 RE Schaijk, The Netherlands
5,
Geert van Amerongen
Geert van Amerongen
5Viroclinics Xplore, Landerd Campus, Nistelrooise Baan 3, 5374 RE Schaijk, The Netherlands
5,
Koert Stittelaar
Koert Stittelaar
5Viroclinics Xplore, Landerd Campus, Nistelrooise Baan 3, 5374 RE Schaijk, The Netherlands
5,
Virginie Jakob
Virginie Jakob
6Vaccine Formulation Institute, Chemin des Aulx 14, 1228 Plan-Les-Ouates, Geneva, Switzerland
6,
Celia Lebas
Celia Lebas
6Vaccine Formulation Institute, Chemin des Aulx 14, 1228 Plan-Les-Ouates, Geneva, Switzerland
6,
Patrick Reading
Patrick Reading
2WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000 Australia
7Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, VIC 3000 Australia
2,7,
Kirsty R Short
Kirsty R Short
1School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072 Australia
3Australian Infectious Diseases Research Centre, Global Virus Network Centre of Excellence, Brisbane, QLD 4072 and 4029 Australia
1,3,
Paul R Young
Paul R Young
1School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072 Australia
3Australian Infectious Diseases Research Centre, Global Virus Network Centre of Excellence, Brisbane, QLD 4072 and 4029 Australia
8The Australian Institute of Biotechnology and Nanotechnology, The University of Queensland, St Lucia, QLD 4072 Australia
1,3,8,✉,
Daniel Watterson
Daniel Watterson
1School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072 Australia
3Australian Infectious Diseases Research Centre, Global Virus Network Centre of Excellence, Brisbane, QLD 4072 and 4029 Australia
8The Australian Institute of Biotechnology and Nanotechnology, The University of Queensland, St Lucia, QLD 4072 Australia
1,3,8,✉,
Keith J Chappell
Keith J Chappell
1School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072 Australia
3Australian Infectious Diseases Research Centre, Global Virus Network Centre of Excellence, Brisbane, QLD 4072 and 4029 Australia
8The Australian Institute of Biotechnology and Nanotechnology, The University of Queensland, St Lucia, QLD 4072 Australia
1,3,8,✉
1School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072 Australia
2WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000 Australia
3Australian Infectious Diseases Research Centre, Global Virus Network Centre of Excellence, Brisbane, QLD 4072 and 4029 Australia
4School of Veterinary Science, The University of Queensland Gatton Campus, Gatton, QLD 4343 Australia
5Viroclinics Xplore, Landerd Campus, Nistelrooise Baan 3, 5374 RE Schaijk, The Netherlands
6Vaccine Formulation Institute, Chemin des Aulx 14, 1228 Plan-Les-Ouates, Geneva, Switzerland
7Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, VIC 3000 Australia
8The Australian Institute of Biotechnology and Nanotechnology, The University of Queensland, St Lucia, QLD 4072 Australia
Subject terms: Protein vaccines, Influenza virus
© The Author(s) 2022
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
